INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue6,00018,723109,066164,995
Cost of Revenue20,830106,011199,109143,633
Gross Profit-14,830-87,288-90,04321,362
Operating Expenses
Research Development----
Selling General and Administrative21,61534,61937,06529,285
Non Recurring----
Others----
Total Operating Expenses42,445140,630236,174172,918
Operating Income or Loss-36,445-121,907-127,108-7,923
Income from Continuing Operations
Total Other Income/Expenses Net-6,10591,806-933-9,310
Earnings Before Interest and Taxes-36,445-121,907-127,108-7,923
Interest Expense-1,010-1,225-1,368-9,649
Income Before Tax-42,550-30,101-128,041-17,233
Income Tax Expense-720-335183
Minority Interest----
Net Income From Continuing Ops-41,830-30,101-128,376-17,416
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-41,830-30,101-128,376-17,416
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-41,830-30,101-128,376-17,416